Submitted:
16 April 2024
Posted:
17 April 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Cell Culture
2.2. Isolation of EVs
2.3. Preparation of EMNVs
2.4. Preparation of NGs
2.5. Preparation of Hybrid NPs
2.6. Cryo-TEM
2.7. Total Protein Measurements
2.8. Total Lipids Measurements
2.9. Western Blotting
2.10. Nanoparticle Tracking Analysis (NTA)
2.11. Dynamic Light Scattering (DLS)
2.12. Native PAGE
2.13. Endolysosomal Escape Analysis
2.14. Colocalization Analysis
2.15. Statistical Analysis
3. Results
3.1. Isolation, Production and Characterization of EVs, NGs and EMNVs
3.2. Fabrication of Hybrid NPs
3.3. Effects of pH on Size and ζ-Potential of Biological and Hybrid NPs
3.4. Mimicking Entrapment of NPs in Lysosomes Reveals Rupture of Hybrid and, to a Lesser Extent, Biological NPs
3.5. EMNVs Escape Endolysosomal Compartment More Efficiently than Hybrid EMNVs-Lipo
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Parodi, A.; Kolesova, E.P.; Voronina, M.V.; Frolova, A.S.; Kostyushev, D.; Trushina, D.B.; et al. Anticancer Nanotherapeutics in Clinical Trials: The Work behind Clinical Translation of Nanomedicine. Int. J. Mol. Sci. 2022, 23, 13368. [Google Scholar] [CrossRef] [PubMed]
- Rodríguez, F.; Caruana, P.; De la Fuente, N.; Español, P.; Gamez, M.; Balart, J.; et al. Nano-based approved pharmaceuticals for cancer treatment: Present and future challenges. Biomolecules 2022, 12, 784. [Google Scholar] [CrossRef]
- Parodi, A.; Buzaeva, P.; Nigovora, D.; Baldin, A.; Kostyushev, D.; Chulanov, V.; et al. Nanomedicine for increasing the oral bioavailability of cancer treatments. J. Nanobiotechnology 2021, 19, 1–19. [Google Scholar] [CrossRef] [PubMed]
- Rao, D.; Huang, D.; Sang, C.; Zhong, T.; Zhang, Z.; Tang, Z. Advances in Mesenchymal Stem Cell-Derived Exosomes as Drug Delivery Vehicles. Front. Bioeng. Biotechnol. 2022, 9, 1–10. [Google Scholar] [CrossRef]
- Kostyushev, D.; Kostyusheva, A.; Brezgin, S.; Smirnov, V.; Volchkova, E.; Lukashev, A.; et al. Gene Editing by Extracellular Vesicles. Int. J. Mol. Sci. 2020, 21, 7362. [Google Scholar] [CrossRef]
- Doyle, L.M. and Wang, M.Z. Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis. Cells.
- Walker, S.; Busatto, S.; Pham, A.; Tian, M.; Suh, A.; Carson, K.; et al. Extracellular vesicle-based drug delivery systems for cancer treatment. Theranostics 2019, 9, 8001. [Google Scholar] [CrossRef]
- Shen, S.; Xie, Z.; Cai, D.; Yu, X.; Zhang, H.; Kim, E.S.; et al. Biogenesis and molecular characteristics of serum hepatitis B virus RNA. PLoS Pathog. 2020, 16, e1008945. [Google Scholar] [CrossRef] [PubMed]
- Phillips, W.; Willms, E. and Hill, A.F. Understanding extracellular vesicle and nanoparticle heterogeneity: Novel methods and considerations. Proteomics. 2021, 21, 1–16. [Google Scholar] [CrossRef] [PubMed]
- Yang, B.; Chen, Y. and Shi, J. Exosome Biochemistry and Advanced Nanotechnology for Next-Generation Theranostic Platforms. Adv. Mater. 2019, 31, 1–33. [Google Scholar] [CrossRef]
- Harding, C. and Stahl, P. Transferrin recycling in reticulocytes: pH and iron are important determinants of ligand binding and processing. Biochem. Biophys. Res. Commun. 1983, 113, 650–658. [Google Scholar] [CrossRef]
- Brezgin, S.; Parodi, A.; Kostyusheva, A.; Ponomareva, N.; Lukashev, A.; Sokolova, D.; et al. Technological aspects of manufacturing and analytical control of biological nanoparticles. Biotechnol. Adv. 2023, 2023, 108122. [Google Scholar] [CrossRef] [PubMed]
- Patel, G.K.; Khan, M.A.; Zubair, H. and Srivastava, S.K. Comparative analysis of exosome isolation methods using culture supernatant for optimum yield, purity and downstream applications. 2019. [Google Scholar] [CrossRef]
- Wu, J.-Y.; Ji, A.-L.; Wang, Z.; Qiang, G.-H.; Qu, Z.; Wu, J.-H.; et al. Exosome-Mimetic Nanovesicles from Hepatocytes promote hepatocyte proliferation in vitro and liver regeneration in vivo. Sci. Rep. 2018, 8, 1–11. [Google Scholar] [CrossRef] [PubMed]
- Kaneti, L.; Bronshtein, T.; Malkah Dayan, N.; Kovregina, I.; Letko Khait, N.; Lupu-Haber, Y.; et al. Nanoghosts as a novel natural nonviral gene delivery platform safely targeting multiple cancers. Nano Lett. 2016, 16, 1574–1582. [Google Scholar] [CrossRef] [PubMed]
- D’Atri, D.; Zerrillo, L.; Garcia, J.; Oieni, J.; Lupu-Haber, Y.; Schomann, T.; et al. Nanoghosts: Mesenchymal Stem cells derived nanoparticles as a unique approach for cartilage regeneration. J. Control. Release 2021, 337, 472–481. [Google Scholar] [CrossRef] [PubMed]
- Ester, N.; Furman, T.; Haber, Y.L.; Bronshtein, T.; Letko, N.; Weinstein, E.; et al. Reconstructed Stem Cell Nano-Ghosts: a Natural Tumor. 2013.
- Sato, Y.T.; Umezaki, K.; Sawada, S.; Mukai, S.; Sasaki, Y.; Harada, N.; et al. Engineering hybrid exosomes by membrane fusion with liposomes. Nat. Publ. Gr. 2016, 1–11. [Google Scholar] [CrossRef]
- Prada, I. and Meldolesi, J. Binding and Fusion of Extracellular Vesicles to the Plasma Membrane of Their Cell Targets. Int. J. Mol. Sci. 2016, 17, 1296. [Google Scholar] [CrossRef] [PubMed]
- Gurung, S.; Perocheau, D.; Touramanidou, L. and Baruteau, J. The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun. Signal. 2021, 19, 47. [Google Scholar] [CrossRef] [PubMed]
- Martens, T.F.; Remaut, K.; Demeester, J.; Smedt, S.C. De and Braeckmans, K. Intracellular delivery of nanomaterials : How to catch endosomal escape in the act. Nano Today 2014, 9, 344–364. [Google Scholar] [CrossRef]
- Buratta, S.; Tancini, B.; Sagini, K.; Delo, F.; Chiaradia, E.; Urbanelli, L.; et al. Lysosomal Exocytosis, Exosome Release and Secretory Autophagy : The Autophagic- and Endo-Lysosomal Systems Go Extracellular. Int. J. Mol. Sci. 2020, 21, 2576. [Google Scholar] [CrossRef]
- Zeng, J.; Shirihai, O.S.; Grinstaff, M.W.; Haven, N.; Angeles, L.; Angeles, L. Modulating lysosomal pH: a molecular and nanoscale materials design perspective. J Life Sci 2021, 2, 25–37. [Google Scholar] [CrossRef]
- Somiya, M. Where does the cargo go?: Solutions to provide experimental support for the “ extracellular vesicle cargo transfer hypothesis.” J. Cell Commun. Signal. 2020, 14, 135–146. [Google Scholar] [CrossRef] [PubMed]
- Heath, N.; Grant, L.; De Oliveira, T.M.; Rowlinson, R.; Osteikoetxea, X.; Dekker, N.; et al. Rapid isolation and enrichment of extracellular vesicle preparations using anion exchange chromatography. Sci. Rep. 2018, 8, 1–12. [Google Scholar]
- Kornilov, R.; Puhka, M.; Mannerström, B.; Hiidenmaa, H.; Peltoniemi, H.; Siljander, P.; et al. Efficient ultrafiltration-based protocol to deplete extracellular vesicles from fetal bovine serum. J. Extracell. vesicles 2018, 7, 1422674. [Google Scholar] [CrossRef] [PubMed]
- Osteikoetxea, X.; Balogh, A.; Szabó-Taylor, K.; Németh, A.; Szabó, T.G.; Pálóczi, K.; et al. Improved characterization of EV preparations based on protein to lipid ratio and lipid properties. PLoS One 2015, 10, e0121184. [Google Scholar] [CrossRef] [PubMed]
- Silachev, D.N.; Goryunov, K.V.; Shpilyuk, M.A.; Beznoschenko, O.S.; Morozova, N.Y.; Kraevaya, E.E.; et al. Effect of MSCs and MSC-Derived Extracellular Vesicles on Human Blood Coagulation. Cells 2019, 8, 258. [Google Scholar] [CrossRef] [PubMed]
- Witwer, K.W.; Goberdhan, D.C.I.; O’Driscoll, L.; Théry, C.; Welsh, J.A.; Blenkiron, C.; et al. Updating MISEV: Evolving the minimal requirements for studies of extracellular vesicles. J. Extracell. Vesicles 2021. [Google Scholar] [CrossRef] [PubMed]
- Liang, Y.; Xu, X.; Xu, L.; Iqbal, Z.; Ouyang, K.; Zhang, H.; et al. Chondrocyte-specific genomic editing enabled by hybrid exosomes for osteoarthritis treatment. Theranostics 2022, 12, 4866. [Google Scholar] [CrossRef] [PubMed]
- Xu, X.; Xu, L.; Wen, C.; Xia, J.; Zhang, Y.; Liang, Y. Programming assembly of biomimetic exosomes: An emerging theranostic nanomedicine platform. Mater. Today Bio 2023, 2023, 100760. [Google Scholar] [CrossRef] [PubMed]
- Li, L.; He, D.; Guo, Q.; Zhang, Z.; Ru, D.; Wang, L.; et al. Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer. J. Nanobiotechnology 2022, 20, 50. [Google Scholar] [CrossRef]
- Wang, F.; Ullah, A.; Fan, X.; Xu, Z.; Zong, R.; Wang, X.; et al. Delivery of nanoparticle antigens to antigen-presenting cells: from extracellular specific targeting to intracellular responsive presentation. J. Control. Release 2021, 333, 107–128. [Google Scholar] [CrossRef]
- Yang, M.M.; Yarragudi, S.B.; Jamieson, S.M.F.; Tang, M.; Wilson, W.R.; Wu, Z. Calcium Enabled Remote Loading of a Weak Acid Into pH-sensitive Liposomes and Augmented Cytosolic Delivery to Cancer Cells via the Proton Sponge Effect. Pharm. Res. 2022, 39, 1181–1195. [Google Scholar] [CrossRef] [PubMed]
- Yan, Y.; Ding, H. pH-responsive nanoparticles for cancer immunotherapy: a brief review. Nanomaterials 2020, 10, 1613. [Google Scholar] [CrossRef] [PubMed]
- Wang, C.; Zhao, T.; Li, Y.; Huang, G.; White, M.A.; Gao, J. Investigation of endosome and lysosome biology by ultra pH-sensitive nanoprobes. Adv. Drug Deliv. Rev. 2017, 113, 87–96. [Google Scholar] [CrossRef] [PubMed]
- Batrakova, E.V.; Kim, M.S.; Hill, C. Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Control Release 2016, 396–405. [Google Scholar] [CrossRef] [PubMed]
- Lin, Y.; Wu, J.; Gu, W.; Huang, Y.; Tong, Z.; Huang, L.; et al. Exosome-Liposome Hybrid Nanoparticles Deliver CRISPR/Cas9 System in MSCs. Adv. Sci. Weinheim, Baden-Wurttemberg, Ger. 2018, 5, 1700611. [Google Scholar] [CrossRef] [PubMed]
- Evers, M.J.W.; Van De Wakker, S.I.; De Groot, E.M.; De Jong, O.G.; Gitz-françois, J.J.J.; Seinen, C.S.; et al. Functional siRNA Delivery by Extracellular Vesicle – Liposome Hybrid Nanoparticles. Adv. Healthc. Mater. 2021, 11, 1–13. [Google Scholar] [CrossRef]
- Brezgin, S.; Kostyusheva, A.; Ponomareva, N.; Bayurova, E.; Kondrashova, A.; Frolova, A.; et al. 2023.
- Borodina, T.; Kostyushev, D.; Zamyatnin Jr, A.A.; Parodi, A. Nanomedicine for treating diabetic retinopathy vascular degeneration. Int. J. Transl. Med. 2021, 1, 306–322. [Google Scholar] [CrossRef]
- Parodi, A.; Kostyushev, D.; Brezgin, S.; Kostyusheva, A.; Borodina, T.; Akasov, R.; et al. Biomimetic approaches for targeting tumor-promoting inflammation. In Seminars in Cancer Biology 2022, pp.
- Chng, W.H.; Muthuramalingam, R.P.K.; Lou, C.K.L.; New, S.; Neupane, Y.R.; Lee, C.K.; et al. Extracellular Vesicles and Their Mimetics: A Comparative Study of Their Pharmacological Activities and Immunogenicity Profiles. Pharmaceutics 2023, 15, 1290. [Google Scholar] [CrossRef] [PubMed]
- Patel, S.; Kim, J.; Herrera, M.; Mukherjee, A.; Kabanov, A.V.; Sahay, G. Brief update on endocytosis of nanomedicines. Adv. Drug Deliv. Rev. 2019, 144, 90–111. [Google Scholar] [CrossRef]
- Smith, S.A.; Selby, L.I.; Johnston, A.P.R.; Such, G.K. The endosomal escape of nanoparticles: toward more efficient cellular delivery. Bioconjug. Chem. 2018, 30, 263–272. [Google Scholar] [CrossRef]
- Wojnilowicz, M.; Glab, A.; Bertucci, A.; Caruso, F. and Cavalieri, F. Super-resolution Imaging of Proton Sponge-Triggered Rupture of Endosomes and Cytosolic Release of Small Interfering RNA. ACS Nano 2019, 13, 187–202. [Google Scholar] [CrossRef] [PubMed]
- Qiu, C.; Xia, F.; Zhang, J.; Shi, Q.; Meng, Y.; Wang, C.; et al. Advanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug Delivery. Res. (Washington, D.C.) 2023, 6, 148. [Google Scholar] [CrossRef] [PubMed]
- Lee, M.; Ban, J.-J.; Im, W.; Kim, M. Influence of storage condition on exosome recovery. Biotechnol. Bioprocess Eng. 2016, 21, 299–304. [Google Scholar] [CrossRef]







Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).